An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth ... “We all we seek to put projections out that we can hit with confidence...within the range of ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

Lilly Chief Financial Officer Lucas Montarce told Reuters last month the drugmaker is trying to balance its demand-generation activities with its ability to supply more patients. The company last year ...

Health experts say popular weight-loss drugs like Ozempic and Wegovy are safe, but the FDA warns counterfeits are becoming more widespread.

But faced with a $1,200 monthly price tag for her weight loss medication ... In states like New York, selling prescription medications without authorization can result in felony charges and ...

On TikTok, where the 31-year-old mother of three chronicled her weight loss ... Zepbound to help with symptoms of the condition as well as maintaining a healthy weight. Since starting the ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular ... even—to really flesh out [that story] completely.” ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs ... about the drugs. “I think there’s still a lot of unknowns out there,” he said.

About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in ... As it turns out, her plan excludes payment for weight-loss drugs.

Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.